| Predicted mean proportion of patients screened given different baseline control proportions | |||||
| QI strategy | OR (95% CrI)a in patients who received QI strategyb | Order | 30% baseline screening (95% CrI) | 50% baseline screening (95% CrI) | 70% baseline screening (95% CrI) |
| CM | 1.09 (0.66 to 1.78) | Bottom | 0.32 (0.22 to 0.43) | 0.52 (0.40 to 0.64) | 0.72 (0.61 to 0.81) |
| TC | 1.60 (0.89 to 2.79) | Top | 0.41 (0.28 to 0.54) | 0.62 (0.47 to 0.74) | 0.79 (0.67 to 0.87) |
| EPR | 1.39 (0.68 to 2.43) | Middle | 0.37 (0.23 to 0.51) | 0.58 (0.41 to 0.71) | 0.76 (0.61 to 0.85) |
| CE | 1.16 (0.82 to 1.63) | Bottom | 0.33 (0.26 to 0.41) | 0.54 (0.45 to 0.62) | 0.73 (0.66 to 0.79) |
| CR | 1.10 (0.70 to 2.09) | Bottom | 0.32 (0.23 to 0.47) | 0.52 (0.41 to 0.68) | 0.72 (0.62 to 0.83) |
| FR | 1.51 (0.57 to 3.65) | Top | 0.39 (0.20 to 0.61) | 0.60 (0.36 to 0.78) | 0.78 (0.57 to 0.89) |
| PE | 1.76 (1.07 to 2.96) | Top | 0.43 (0.31 to 0.56) | 0.64 (0.52 to 0.75) | 0.80 (0.71 to 0.87) |
| PSM | 1.29 (0.67 to 2.46) | Middle | 0.36 (0.22 to 0.51) | 0.56 (0.40 to 0.71) | 0.75 (0.61 to 0.85) |
| PR | 1.70 (0.79 to 3.57) | Top | 0.42 (0.25 to 0.60) | 0.63 (0.44 to 0.78) | 0.80 (0.65 to 0.89) |
| Other | 1.12 (0.76 to 1.50) | Bottom | 0.32 (0.25 to 0.39) | 0.53 (0.43 to 0.60) | 0.72 (0.64 to 0.78) |